For the year ending 2025-12-31, ESAB had -$63,495K decrease in cash & cash equivalents over the period. $213,280K in free cash flow.
| Cash Flow | 2025-12-31 |
|---|---|
| Net income | 233,232 |
| Depreciation, amortization and other impairment charges | 84,105 |
| Net gain on sale of property, plant and equipment | 5,645 |
| Stock-based compensation expense | 16,937 |
| Deferred income tax benefit | -35,664 |
| Non-cash interest expense | 2,864 |
| Pension settlement loss | 0 |
| Trade receivables, net | 40,014 |
| Inventories, net | 5,570 |
| Accounts payable | 6,687 |
| Other operating assets and liabilities | -3,635 |
| Net cash provided by operating activities | 260,567 |
| Purchases of property, plant and equipment | 47,287 |
| Proceeds from sale of property, plant and equipment | 6,535 |
| Acquisitions, net of cash received | 438,314 |
| Payment for (proceeds from) other investing activity | 816 |
| Net cash used in investing activities | -479,882 |
| Proceeds from borrowings on senior notes | 0 |
| Proceeds from borrowings on term loan | 350,000 |
| Proceeds from borrowings on revolving credit facilities and other | 410,715 |
| Repayments of borrowings on term loan | 385,000 |
| Repayments of borrowings on revolving credit facilities and other | 217,149 |
| Payment of debt issuance costs | 5,396 |
| Payment of dividends | 21,913 |
| Distributions to noncontrolling interest holders | 4,171 |
| Other financing | -13,385 |
| Net cash provided by (used in) financing activities | 113,701 |
| Effect of foreign exchange rates on cash and cash equivalents | 42,119 |
| (decrease) increase in cash and cash equivalents | -63,495 |
| Cash and cash equivalents, beginning of period | 249,358 |
| Cash and cash equivalents, end of period | 185,863 |
ESAB Corp (ESAB)
ESAB Corp (ESAB)